SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Indications -- Hepatitis
An SI Board Since March 2001
Posts SubjectMarks Bans
312 28 0
Emcee:  tuck Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
112New Insights Into Protein Synthesis and Hepatitis C Infections Fri Dec 2 11:03John McCarthy-12/4/2005
111Idenix Provides Update on Clinical Development Program for Valopicitabine (NM283John McCarthy-12/2/2005
110MIGENIX Initiates Enrollment in Phase IIb Hepatitis C Clinical Study of CelgosivJohn McCarthy-11/22/2005
109Novartis: hepatitis B pill better than standard drug UPDATE 1-Novartis: hepatitJohn McCarthy-11/14/2005
108PEG-INTRON(R) and REBETOL(R) Combination Therapy Demonstrates Consistently High John McCarthy-11/12/2005
107Vertex Pharma Files for Mid-Stage Study Friday November 11, 11:21 am ET VerteJohn McCarthy-11/11/2005
106Valopicitabine (NM283) Combined with Pegylated Interferon Demonstrated SignificaJohn McCarthy-11/11/2005
105Idenix hepatitis C pill shows promise in trial Fri Nov 11, 2005 11:00 AM ET NJohn McCarthy-11/11/2005
104IDIX - Coverage initiated by Citigroup From: To:Buy finance.yahoo.comJohn McCarthy-11/9/2005
103Leerink Swann & Company Initiates Coverage of Idenix Pharmaceuticals, Inc. (John McCarthy-11/9/2005
102Biolex Initiates Phase 1 Clinical Study of Hepatitis C Candidate Locteron(TM) John McCarthy-11/2/2005
101Idenix May Have 'Best-In-Class' Hepatitis Treatment Peter Kang, 10.04.John McCarthy-10/4/2005
100Press Release Source: Bioenvision, Inc. Bioenvision's Phase II Trial of ViLJM-9/28/2005
992005 - 2005 - O.T. - Flamel Technologies: Positive Phase I/II Trial Results For John McCarthy-9/26/2005
982005 - Anadys Drug May Become Cornerstone Hepatitis Therapy Peter Kang, 09.21.0John McCarthy-9/26/2005
97Nature blurb about Entecavir, BMS' new Hep B drug: nature.com Free registrtuck-7/5/2005
96VRTX HCV results.. Message 21309755zeta1961-5/10/2005
95Message 21304158 Hi Tuck..DDW completely went off my radar..just scanned for anzeta1961-5/8/2005
94Digestive Diseases Week starts May 14th. Here's the abstract search engine tuck-4/28/2005
93[IMMUNOLOGY OF HEPATITIS B VIRUS AND HEPATITIS C VIRUS INFECTION] Nature Revituck-3/10/2005
92Thanks Russett for that post..interesting..more studies should illuminate..at tizeta1961-2/23/2005
91Canadian scientists may have found why hepatitis C triggers chronic infection Hrusset-2/23/2005
90<i>geranylgeranylation</i> wow..I can't pronounce that word andzeta1961-2/8/2005
89[HCV RNA replication is regulated by host geranylgeranylation and fatty acids] tuck-2/8/2005
88Bristol Entecavir Hepatitis Therapy Slated For Antiviral Cmte. Review [BMY seemzeta1961-1/25/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News